NOT KNOWN FACTUAL STATEMENTS ABOUT BLOCK PAIN RECEPTORS WITH PROLEVIATE

Acquiring discovered the palmitoylation motif of APLNR, we designed a brief substrate sequence to competitively inhibit the palmitoylation of endogenous APLNR. This competitive peptide, which targets the APLNR palmitoylation web page together with morphine, can inhibit the development of NCP, including pain incidence, microglial activation, and inf